Condensed Statements of Changes in Shareholders' Deficit - USD ($)		Total	Ordinary shares [Member] Class A ordinary share [Member]	Ordinary shares [Member] Class B ordinary share [Member]		Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Beginning balance, shares at Mar. 23, 2025			0	0	[1]
Beginning balance, amount at Mar. 23, 2025		$ 0	$ 0	$ 0	[1]	$ 0	$ 0
Issuance of Class B ordinary shares to Sponsor, shares	[1]			11,500,000
Issuance of Class B ordinary shares to Sponsor, amount		25,000		$ 1,150	[1]	23,850
Net Income (Loss)		(20,608)					(20,608)
Ending balance, shares at Mar. 31, 2025			0	11,500,000	[1]
Ending balance, amount at Mar. 31, 2025		4,392	$ 0	$ 1,150	[1]	23,850	(20,608)
Beginning balance, shares at Mar. 23, 2025			0	0	[1]
Beginning balance, amount at Mar. 23, 2025		0	$ 0	$ 0	[1]	0	0
Accretion of carrying value to redemption value		(31,348,443)
Ending balance, shares at Dec. 31, 2025			900,000	11,500,000
Ending balance, amount at Dec. 31, 2025		(15,199,198)	$ 90	$ 1,150		0	(15,200,438)
Accretion of carrying value to redemption value		(4,270,890)					(4,270,890)
Net Income (Loss)		4,013,166					4,013,166
Ending balance, shares at Mar. 31, 2026			900,000	11,500,000
Ending balance, amount at Mar. 31, 2026		$ (15,456,922)	$ 90	$ 1,150		$ 0	$ (15,458,162)

[1] Included up to 1,500,000 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. Subsequently, on October 1, 2025, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 1,500,000 Founder Shares are no longer subject to forfeiture (see Note 4).